Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Fourmy

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Trends in Pharmacological Sciences|December 25, 2002
Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors?Elodie Archer, Bernard Maigret, Chantal Escrieut, et al.
Trends in Pharmacological Sciences|April 25, 2013
Sulfur-containing amino acids in 7TMRs: molecular gears for pharmacology and functionArnau Cordomí, José C Gómez-Tamayo, Véronique Gigoux, et al.
The Journal of Clinical Endocrinology and Metabolism|November 25, 2011
Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumorsBeatrice Waser, Ruth Rehmann, Claire Sanchez, et al.
The Journal of Biological Chemistry|December 16, 2010
Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonistsRémi Magnan, Bernard Masri, Chantal Escrieut, et al.
Peptides|December 21, 2019
GIP receptor: Expression in neuroendocrine tumours, internalization, signalling from endosomes and structure-function relationship studiesJean Claude Reubi, Daniel Fourmy, Arnau Cordomi, et al.
Biophysical Journal|December 6, 2005
Probing a model of a GPCR/ligand complex in an explicit membrane environment: the human cholecystokinin-1 receptorJérôme Hénin, Bernard Maigret, Mounir Tarek, et al.
The Journal of Biological Chemistry|October 22, 2008
Linking non-peptide ligand binding mode to activity at the human cholecystokinin-2 receptorMagali Foucaud, Esther Marco, Chantal Escrieut, et al.
Nanomaterials (Basel, Switzerland)|June 30, 2018
Combined Treatments of Magnetic Intra-Lysosomal Hyperthermia with Doxorubicin Promotes Synergistic Anti-Tumoral ActivityDarine El Hajj Diab, Pascal Clerc, Nizar Serhan, et al.
Oncogene|October 26, 2002
Gastrin mediated cholecystokinin-2 receptor activation induces loss of cell adhesion and scattering in epithelial MDCK cellsChristiane Bierkamp, Aline Kowalski-Chauvel, Stephanie Dehez, et al.
Pharmacology & Toxicology|April 12, 2003
Transgenic mice expressing cholecystokinin 2 receptors in the pancreasPascal Clerc, Corinne Saillan-Barreau, Christine Desbois, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Trends in Pharmacological Sciences|December 25, 2002
Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors?Elodie Archer, Bernard Maigret, Chantal Escrieut, et al.
Trends in Pharmacological Sciences|April 25, 2013
Sulfur-containing amino acids in 7TMRs: molecular gears for pharmacology and functionArnau Cordomí, José C Gómez-Tamayo, Véronique Gigoux, et al.
The Journal of Clinical Endocrinology and Metabolism|November 25, 2011
Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumorsBeatrice Waser, Ruth Rehmann, Claire Sanchez, et al.
The Journal of Biological Chemistry|December 16, 2010
Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonistsRémi Magnan, Bernard Masri, Chantal Escrieut, et al.
Peptides|December 21, 2019
GIP receptor: Expression in neuroendocrine tumours, internalization, signalling from endosomes and structure-function relationship studiesJean Claude Reubi, Daniel Fourmy, Arnau Cordomi, et al.
Biophysical Journal|December 6, 2005
Probing a model of a GPCR/ligand complex in an explicit membrane environment: the human cholecystokinin-1 receptorJérôme Hénin, Bernard Maigret, Mounir Tarek, et al.
The Journal of Biological Chemistry|October 22, 2008
Linking non-peptide ligand binding mode to activity at the human cholecystokinin-2 receptorMagali Foucaud, Esther Marco, Chantal Escrieut, et al.
Nanomaterials (Basel, Switzerland)|June 30, 2018
Combined Treatments of Magnetic Intra-Lysosomal Hyperthermia with Doxorubicin Promotes Synergistic Anti-Tumoral ActivityDarine El Hajj Diab, Pascal Clerc, Nizar Serhan, et al.
Oncogene|October 26, 2002
Gastrin mediated cholecystokinin-2 receptor activation induces loss of cell adhesion and scattering in epithelial MDCK cellsChristiane Bierkamp, Aline Kowalski-Chauvel, Stephanie Dehez, et al.
Pharmacology & Toxicology|April 12, 2003
Transgenic mice expressing cholecystokinin 2 receptors in the pancreasPascal Clerc, Corinne Saillan-Barreau, Christine Desbois, et al.
Pageof 8